Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bivalirudin Plus Prasugrel vs Abciximab Plus Clopidogrel. Optimizing Ischemic Protection and Bleeding Risk in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

NCT01158846 is registered in ClinicalTrials.gov with I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio as lead sponsor.

NCT NCT01158846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01158846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bivalirudin Plus Prasugrel vs Abciximab Plus Clopidogrel. Optimizing Ischemic Protection and Bleeding Risk in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Lead sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2010
Completion date
June 30, 2011
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary percutaneous coronary intervention, st-elevation myocardial infarction